SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-17-006970
Filing Date
2017-08-04
Accepted
2017-08-04 16:17:00
Documents
3
Effectiveness Date
2017-08-04

Document Format Files

Seq Description Document Type Size
1 DEFA 14A vtgndefa14a.htm DEFA14A 22679
2 IMAGE defa14anotice000.jpg GRAPHIC 92146
3 IMAGE defa14anotice001.jpg GRAPHIC 105119
  Complete submission text file 0001654954-17-006970.txt   295722
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37761 | Film No.: 171008836
SIC: 2834 Pharmaceutical Preparations